For press inquiries click here to contact us.
Council on Foreign Relations
The Growing U.S. Opioid Crisis: Lessons From Around the World
Axios
Verily co-founder jumps to health care venture firm
Business Wire
Foresite Capital Announces CEO Jim Tananbaum Named to Forbes’ Midas List 2017
Forbes
Foresite Capital CEO Jim Tananbaum Featured on the Forbes Midas List for the Third Year in a Row
Xconomy
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund
FierceBiotech
Biotech Foresite Capital Reloads With A $450M Biotech Venture Fund
Forbes
The Top Life Science Investors Of The 2015 Midas List
The Huffington Post
New Possibilities For People Who Suffer From Nut Allergies
Xconomy
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund
Recognitions by unaffiliated third parties should not be construed as a current or past endorsement of Foresite Capital Management, LLC (“Foresite Capital”) or the private funds it manages. The rankings and recognitions published by Forbes are based on information prepared and submitted by Foresite Capital. Third party ratings are not representative of an individual investor’s investment results or the results of Foresite Capital and its funds. Past performance is no guarantee of future results. Please contact Foresite Capital for more detail on the criteria upon which the Forbes Midas List is based.